Assessment of Prostate-Specific Antigen Doubling Time in Prediction of Prostate Cancer on Needle Biopsy

Urology

Volumn 69, Issue 5, 2007, Pages 931-935

  Spurgeon, Stephen E F ^a   Mongoue Tchokote, Solange ^b   Collins, Lauren ^b   Priest, Ryan ^b   Hsieh, Yi Ching ^b   Peters, Laura M ^c   Beer, Tomasz M ^a   Mori, Motomi ^b   Garzotto, Mark ^b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CONFIDENCE INTERVAL; DEMOGRAPHY; DIGITAL RECTAL EXAMINATION; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PATIENT REFERRAL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SCORING SYSTEM;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CONFIDENCE INTERVALS; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 34247598299     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.01.075     Document Type: Article

References (15)

1. Stamey T.A. The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA. BJU Int 94 (2004) 963-964
2. Thompson I.M., Ankerst D.P., Chi C., et al. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. JAMA 294 (2005) 66-70
3. Carter H.B., Pearson J.D., Metter E.J., et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267 (1992) 2215-2220
4. Freedland S.J., Humphreys E.B., Mangold L.A., et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294 (2005) 433-439
5. D'Amico A.V., Cote K., Loffredo M., et al. Determinants of prostate cancer specific survival following radiation therapy during the prostate specific antigen era. J Urol 170 (2003) S42-S47
6. Eastham J.A., Riedel E., Scardino P.T., et al. Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. JAMA 289 (2003) 2695-2700
7. Nixon R.G., Wener M.H., Smith K.M., et al. Biological variation of prostate specific antigen levels in serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients. J Urol 157 (1997) 2183-2190
8. Fang J., Metter E.J., Landis P., et al. PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml. Urology 59 (2002) 889-894
9. Thompson I.M., Ankerst D.P., Chi C., et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 98 (2006) 529-534
10. Raaijmakers R., Wildhagen M.F., Ito K., et al. Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, Section Rotterdam. Urology 63 (2004) 316-320
11. Garzotto M., Hudson R.G., Peters L., et al. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mL. Cancer 98 (2003) 1417-1422
12. Catalona W.J., Smith D.S., Ratliff T.L., et al. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270 (1993) 948-954
13. Schroder F.H., van der Maas P., Beemsterboer P., et al. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer: Evaluation of the digital rectal examination as a screening test for prostate cancer. J Natl Cancer Inst 90 (1998) 1817-1823
14. Djavan B., Remzi M., Zlotta A., et al. Novel artificial neural network for early detection of prostate cancer. J Clin Oncol 20 (2002) 921-929
15. Garzotto M., Beer T.M., Hudson R.G., et al. Improved detection of prostate cancer using classification and regression tree analysis. J Clin Oncol 23 (2005) 4322-4329